Free Analysis

Data-driven stock analysis, valuation deep dives, and financial forensics. Every article backed by the numbers.

ValuationLLY

Eli Lilly vs Merck: Where the Pharma Re-Rating Goes Next

LLY trades at 26.7x forward on GLP-1 growth. MRK trades at 22x forward on a Keytruda cliff. The Valuation Desk compares the two franchises on durability, pipeline, and execution to identify the next leg of pharma outperformance.

Apr 24, 2026
ValuationJPM

JPMorgan vs Goldman: Which Bank Actually Earns Its Premium?

JPM trades at 14.5x forward versus GS at 15.7x. The Valuation Desk runs both names through identical frameworks to identify which franchise justifies its current multiple.

Apr 24, 2026
Market SignalsAMZN

Five Things the Market Is Missing About Amazon's Ad Business

Advertising revenue has scaled into a three-digit billions business with margins far above the retail complex. The Signals Desk reads the segment as more important than the consensus models price it.

Apr 24, 2026
Market SignalsAAPL

Five Things the Market Is Missing About Apple's Services Mix

Services revenue now produces an outsized share of operating income while hardware growth is flat. The Signals Desk identifies five specific data points the Street consensus is mispricing.

Apr 24, 2026
Deep DivesBHP

Inside BHP's Copper Transition

Iron ore still pays the bills. Copper builds the future. The Research Desk looks inside BHP's capital allocation across Escondida, Oak Dam, and Canadian potash to test whether the transition is priced correctly at 15x forward.

Apr 24, 2026
Market SignalsCOP

ConocoPhillips Heads Into Q1 With the Cheapest Multiple in the Majors

Consensus expects an earnings beat. COP trades at 12.9x forward versus XOM at 14.3x and CVX at 13.8x. The Signals Desk reads the discount as a transient mispricing around the Marathon integration.

Apr 24, 2026
ValuationFCX

Freeport Is Priced for a Copper Cycle That Has Already Started

Q1 2026 call disclosed rising grades and steady production. FCX trades at 3.9x sales and 15.0x EV/EBITDA. The Valuation Desk thinks the market is paying for historical margins, not the ones the copper cycle is about to deliver.

Apr 24, 2026
RiskTSLA

The Street Celebrated Tesla's Q1 Beat. The Risk Desk Isn't Buying It.

Q1 2026 surpassed consensus on both lines. Revenue is flat for three years, operating margin has collapsed to 4.7 percent, and net income halved. At $1.45 trillion market cap, the consensus view is that the bottom is in. The data says otherwise.

Apr 24, 2026
Deep DivesNVDA

Three Chip Cycles Point to the Same Conclusion on Nvidia's Physical AI Push

FY26 revenue reached $215.9B with operating margin at 65 percent. The Research Desk looks at three prior cycles to test whether the Physical AI narrative creates a fourth leg or marks the cycle top.

Apr 24, 2026
Capital AllocationMSFT

Microsoft's First Voluntary Buyout Says More About FY2027 Than FY2026

Microsoft has never offered a voluntary employee buyout. It just did. The Capital Desk reads the signal as capex prioritisation, not cost distress.

Apr 24, 2026
RiskMETA

Meta's 8,000 Layoffs Are a Margin Move, Not a Confidence Vote

Capex doubled to $69.7B while free cash flow compressed $8B. The layoffs protect operating margin. They do not protect the free cash flow yield investors are paying 22.6x forward earnings for.

Apr 24, 2026
Market SignalsINTC

Intel's Q2 Guidance Just Rewrote the Comeback Story

Q1 revenue of $13.58B beat consensus by $1.15B and Q2 guidance came in above estimates. Intel now trades on a comeback narrative the cash flow statement has not ratified.

Apr 24, 2026
Market SignalsBHP

Three Mining Names The Signals Say Are Mispriced: BHP, Rio Tinto, Freeport

Apr 23, 2026
Capital AllocationXOM

Five Things Every Exxon Investor Should Know About The Plastics Pivot

Apr 23, 2026
RiskCAT

Caterpillar Update: Six Months On, The Cyclical Warning Is Now Signal

Apr 23, 2026